000 | 01892 a2200517 4500 | ||
---|---|---|---|
005 | 20250516151927.0 | ||
264 | 0 | _c20140128 | |
008 | 201401s 0 0 eng d | ||
022 | _a1557-3265 | ||
024 | 7 |
_a10.1158/1078-0432.CCR-12-3478 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhao, Jun | |
245 | 0 | 0 |
_aAnti-HDGF targets cancer and cancer stromal stem cells resistant to chemotherapy. _h[electronic resource] |
260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cJul 2013 |
||
300 |
_a3567-76 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Profiling |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xmetabolism |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Grading |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aNeoplastic Stem Cells _xdrug effects |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 |
_aStromal Cells _xdrug effects |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aMa, Mark Z | |
700 | 1 | _aRen, Hening | |
700 | 1 | _aLiu, Zhenqiu | |
700 | 1 | _aEdelman, Martin J | |
700 | 1 | _aPan, Hong | |
700 | 1 | _aMao, Li | |
773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 19 _gno. 13 _gp. 3567-76 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-12-3478 _zAvailable from publisher's website |
999 |
_c22770156 _d22770156 |